Christopher J. Scoggins

Christopher J. Scoggins

Executive Vice President, Diabetes CareatAbbott Laboratories· In the 2025 proxy

Pay in FY2025

Christopher J. Scoggins was paid $6.6M in FY2025 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Abbott Laboratories proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Abbott LaboratoriesPublic company · 1 yr
    • Executive Vice President, Diabetes Care2025 – Present · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?